You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dent 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prospective Research Rare Kidney Stones (ProRKS)

Recruiting
  • Hyperoxaluria
  • +4 more
    • Birmingham, Alabama
    • +10 more
    Nov 10, 2022

    PJ-011726 IntelliSpace Cognition MCI Study

    Completed
    • MCI
    • Cognitive Function 1, Social
    • IntelliSpace Cognition
    • Amherst, New York
      DENT Neurologic Institute
    Jul 15, 2022

    High Grade Glioma Trial in Lake Success (5 Aminolevulinic Acid, CV01-delivered ultrasound)

    Recruiting
    • High Grade Glioma
    • 5 Aminolevulinic Acid
    • CV01-delivered ultrasound
    • Saint Louis, Missouri
    • +2 more
    Dec 21, 2022

    Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

    Recruiting
    • Adenine Phosphoribosyltransferase Deficiency
    • +83 more
      • Bristol, South West, United Kingdom
        Zoe Plummer
      Sep 26, 2023

      Chronic Migraine in Children Trial in Worldwide (Eptinezumab, Placebo)

      Recruiting
      • Chronic Migraine in Children
      • Hialeah, Florida
      • +15 more
      Aug 17, 2022

      Migraine Trial in United States (AMG 334 Dose 1, AMG 334 Dose 2, AMG 334 Dose 3)

      Terminated
      • Migraine
      • AMG 334 Dose 1
      • +2 more
      • Little Rock, Arkansas
      • +13 more
      Feb 10, 2022

      Chronic Cluster Headache Trial in Worldwide (Eptinezumab)

      Active, not recruiting
      • Chronic Cluster Headache
      • Stamford, Connecticut
      • +30 more
      Jan 18, 2023

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

      Active, not recruiting
      • Primary Progressive Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
      • ATA188
      • Placebo
      • La Jolla, California
      • +33 more
      Jul 21, 2022

      Migraine Trial in United States (Rimegepant 75mg daily dosing, Rimegepant 75mg every other day dosing, Placebo comparator

      Recruiting
      • Migraine
      • Rimegepant 75mg daily dosing
      • +2 more
      • Tempe, Arizona
      • +55 more
      Jan 18, 2023

      Cognition Disorders Trial in Worldwide (Placebo, Solanezumab)

      Active, not recruiting
      • Cognition Disorders
      • Birmingham, Alabama
      • +67 more
      Jan 17, 2023

      Rare Kidney Stone Consortium Patient Registry

      Recruiting
      • Primary Hyperoxaluria
      • +3 more
        • Rochester, Minnesota
        • +3 more
        Aug 19, 2022

        Myasthenia Gravis Trial in Canada, United States (RVT-1401, Placebo)

        Completed
        • Myasthenia Gravis
        • Mobile, Alabama
        • +19 more
        Oct 6, 2021

        Subjective Tinnitus Trial in Worldwide (OTO-313, Placebo)

        Completed
        Has Results
        • Subjective Tinnitus
        • Fresno, California
        • +47 more
        Dec 13, 2022

        Migraine Trial in Worldwide (Erenumab Dose 1, Erenumab Dose 2, Erenumab Dose 3)

        Recruiting
        • Migraine
        • Erenumab Dose 1
        • +3 more
        • Aurora, Colorado
        • +88 more
        Feb 1, 2023

        Migraine Trial in Worldwide (Erenumab Dose 1, Erenumab Dose 2, Erenumab Dose 3)

        Recruiting
        • Migraine
        • Erenumab Dose 1
        • +3 more
        • Aurora, Colorado
        • +82 more
        Dec 6, 2022

        Migraine Trial in Australia, Canada, United States (ABP-450, Placebo)

        Recruiting
        • Migraine
        • Chandler, Arizona
        • +62 more
        Jan 30, 2023

        Parkinson Disease Trial in Worldwide (Placebo, PF-06649751 low dose (1 mg QD), PF-06649751 middle dose 1 (3 mg QD))

        Terminated
        Has Results
        • Parkinson Disease
        • Placebo
        • +4 more
        • Phoenix, Arizona
        • +56 more
        Oct 28, 2020

        Rare Kidney Stone Consortium Biobank

        Recruiting
        • Primary Hyperoxaluria
        • +3 more
          • Rochester, Minnesota
            Mayo Clinic
          Jul 8, 2021

          Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol

          Recruiting
          • Mild Cognitive Impairment (MCI)
          • Alzheimer's Disease (AD)
            • Birmingham, Alabama
            • +58 more
            Jun 15, 2022

            Episodic Migraine Trial in Worldwide (Atogepant, Placebo-Matching Atogepant)

            Not yet recruiting
            • Episodic Migraine
            • Huntsville, Alabama
            • +89 more
            Jan 26, 2023

            Episodic Migraine Trial in Worldwide (Atogepant)

            Not yet recruiting
            • Episodic Migraine
            • Huntsville, Alabama
            • +88 more
            Jan 24, 2023

            Multiple Sclerosis Trial in Canada, Puerto Rico, United States (RPC-1063)

            Recruiting
            • Multiple Sclerosis
            • Birmingham, Alabama
            • +110 more
            Jan 3, 2023

            ALS Trial in Worldwide (MT-1186, Placebo)

            Recruiting
            • ALS
            • Phoenix, Arizona
            • +94 more
            Dec 9, 2022

            Alzheimer's Disease Neuroimaging Initiative 2

            Completed
            • Mild Cognitive Impairment (MCI)
            • +4 more
            • Birmingham, Alabama
            • +57 more
            Feb 11, 2022

            Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Antihistamine, Methylprednisolone)

            Recruiting
            • Multiple Sclerosis
            • Cullman, Alabama
            • +202 more
            Jan 27, 2023